Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

Medscape Oncology Global - Improving Outcomes in Patients With High-Risk HR+/HER2- EBC: Keeping the Patient Central

How Would You Assess Risk of Recurrence in This Patient With HR+/HER2- EBC? Patient video will be included

Date

10 Sep 2022

Session

Medscape Oncology Global - Improving Outcomes in Patients With High-Risk HR+/HER2- EBC: Keeping the Patient Central

Topics

Endocrine Therapy;  Targeted Therapy

Tumour Site

Breast Cancer

Presenters

Wolfgang Janni

Authors

W. Janni

Author affiliations

  • Frauenklinik, Ulm Medical University, 89081 - Ulm/DE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and introduction 

Presenter: Joyce O'Shaughnessy

Session: Medscape Oncology Global - Improving Outcomes in Patients With High-Risk HR+/HER2- EBC: Keeping the Patient Central

Resources:

Webcast

Concluding Remarks

Presenter: Joyce O'Shaughnessy

Session: Medscape Oncology Global - Improving Outcomes in Patients With High-Risk HR+/HER2- EBC: Keeping the Patient Central

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.